Eisai Co., Ltd.

TSE:4523 株式レポート

時価総額：JP¥1.4t

Eisai 過去の業績

過去 基準チェック /06

Eisai's earnings have been declining at an average annual rate of -21.5%, while the Pharmaceuticals industry saw earnings growing at 3.4% annually. Revenues have been growing at an average rate of 3% per year. Eisai's return on equity is 3.7%, and it has net margins of 4.4%.

主要情報

-21.5%

収益成長率

-21.6%

EPS成長率

Pharmaceuticals 業界の成長3.4%
収益成長率3.0%
株主資本利益率3.7%
ネット・マージン4.4%
次回の業績アップデート08 Nov 2024

最近の業績更新

Recent updates

Is Eisai (TSE:4523) Using Too Much Debt?

Oct 15
Is Eisai (TSE:4523) Using Too Much Debt?

Eisai (TSE:4523) Is Paying Out A Dividend Of ¥80.00

Sep 20
Eisai (TSE:4523) Is Paying Out A Dividend Of ¥80.00

Eisai (TSE:4523) Has Affirmed Its Dividend Of ¥80.00

Sep 05
Eisai (TSE:4523) Has Affirmed Its Dividend Of ¥80.00

Eisai (TSE:4523) Has Affirmed Its Dividend Of ¥80.00

Aug 08
Eisai (TSE:4523) Has Affirmed Its Dividend Of ¥80.00

Eisai (TSE:4523) Is Due To Pay A Dividend Of ¥80.00

Jul 25
Eisai (TSE:4523) Is Due To Pay A Dividend Of ¥80.00

Is Eisai (TSE:4523) A Risky Investment?

Jul 11
Is Eisai (TSE:4523) A Risky Investment?

Eisai (TSE:4523) Has Affirmed Its Dividend Of ¥80.00

Jul 11
Eisai (TSE:4523) Has Affirmed Its Dividend Of ¥80.00

Eisai Co., Ltd.'s (TSE:4523) P/E Is On The Mark

Jun 10
Eisai Co., Ltd.'s (TSE:4523) P/E Is On The Mark

Here's Why Eisai (TSE:4523) Can Manage Its Debt Responsibly

Apr 11
Here's Why Eisai (TSE:4523) Can Manage Its Debt Responsibly

Eisai (TSE:4523) Has Affirmed Its Dividend Of ¥80.00

Mar 18
Eisai (TSE:4523) Has Affirmed Its Dividend Of ¥80.00

Eisai's (TSE:4523) Dividend Will Be ¥80.00

Mar 04
Eisai's (TSE:4523) Dividend Will Be ¥80.00

収支内訳

Eisai の稼ぎ方とお金の使い方。LTMベースの直近の報告された収益に基づく。

収益と収入の歴史

TSE:4523 収益、費用、利益 ( )JPY Millions
日付収益収益G+A経費研究開発費
30 Jun 24733,84532,648387,882169,347
31 Mar 24741,75142,406364,084169,021
31 Dec 23749,46045,421346,208176,070
30 Sep 23759,32948,096346,619174,257
30 Jun 23757,07548,874341,916175,647
31 Mar 23744,40255,432348,139172,999
31 Dec 22737,09826,705373,875169,848
30 Sep 22752,50032,233382,752173,324
30 Jun 22741,59432,690374,428168,422
31 Mar 22756,22647,954356,847171,738
31 Dec 21712,93557,311317,150165,418
30 Sep 21691,25062,508293,153162,699
30 Jun 21679,25359,855282,369161,584
31 Mar 21645,94242,119272,568150,299
31 Dec 20707,88893,682271,476145,248
30 Sep 20713,400120,571261,973139,628
30 Jun 20707,203124,523253,516141,217
31 Mar 20695,621121,767248,554140,116
31 Dec 19661,64696,659244,091146,367
30 Sep 19631,97457,725239,503147,863
30 Jun 19643,53172,747233,180140,143
31 Mar 19642,83463,386223,798144,844
31 Dec 18627,36763,714212,469139,100
30 Sep 18625,10665,679195,229138,461
30 Jun 18611,49954,347186,198140,514
31 Mar 18600,05451,845179,915139,579
31 Dec 17569,81429,048178,312134,955
30 Sep 17554,27630,269178,090123,639
30 Jun 17544,02729,425176,249119,503
31 Mar 17539,09739,358175,633112,478
31 Dec 16530,69655,031175,240110,471
30 Sep 16542,31371,812178,825114,420
30 Jun 16545,60269,227182,036115,750
31 Mar 16547,92254,933188,227122,307
31 Dec 15566,43544,886192,375125,396
30 Sep 15554,91243,871191,627132,652
30 Jun 15554,88543,021192,617135,534
31 Mar 15548,46543,254189,910131,907
31 Dec 14560,79540,15290,324228,412
30 Sep 14561,93815,717126,410192,643
30 Jun 14578,94529,225163,903159,644
31 Mar 14600,36332,955210,544130,544
31 Dec 13590,15243,756223,092120,377

質の高い収益: 4523 has a large one-off gain of ¥8.6B impacting its last 12 months of financial results to 30th June, 2024.

利益率の向上: 4523's current net profit margins (4.4%) are lower than last year (6.5%).

フリー・キャッシュフローと収益の比較

過去の収益成長分析

収益動向: 4523's earnings have declined by 21.5% per year over the past 5 years.

成長の加速: 4523's has had negative earnings growth over the past year, so it can't be compared to its 5-year average.

収益対業界: 4523 had negative earnings growth (-33.2%) over the past year, making it difficult to compare to the Pharmaceuticals industry average (38.7%).

株主資本利益率

高いROE: 4523's Return on Equity (3.7%) is considered low.

総資産利益率

使用総資本利益率

過去の好業績企業の発掘

7D

1Y

7D

1Y

7D

1Y